International Consensus on Minimum Preclinical Testing Requirements for the Development of Innovative Therapies For Children and Adolescents with Cancer
- DOI
- 10.1158/1535-7163.mct-20-0394
- Published
- 2021-06-09
- Container
- Molecular Cancer Therapeutics
- Publisher
- American Association for Cancer Research (AACR)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1158/1535-7163.mct-20-0394,
title = {International Consensus on Minimum Preclinical Testing Requirements for the Development of Innovative Therapies For Children and Adolescents with Cancer},
author = {Gilles Vassal and Peter J. Houghton and Stefan M. Pfister and Malcolm A. Smith and Huib N. Caron and Xiao-Nan Li and David J. Shields and Olaf Witt and Jan J. Molenaar and Sara Colombetti and Julia Schüler and Lou F. Stancato},
year = {2021},
journal = {Molecular Cancer Therapeutics},
doi = {10.1158/1535-7163.mct-20-0394},
url = {https://doi.org/10.1158/1535-7163.mct-20-0394}
}RIS
TY - JOUR TI - International Consensus on Minimum Preclinical Testing Requirements for the Development of Innovative Therapies For Children and Adolescents with Cancer AU - Gilles Vassal AU - Peter J. Houghton AU - Stefan M. Pfister AU - Malcolm A. Smith AU - Huib N. Caron AU - Xiao-Nan Li AU - David J. Shields AU - Olaf Witt AU - Jan J. Molenaar AU - Sara Colombetti AU - Julia Schüler AU - Lou F. Stancato PY - 2021 JO - Molecular Cancer Therapeutics DO - 10.1158/1535-7163.mct-20-0394 UR - https://doi.org/10.1158/1535-7163.mct-20-0394 ER -
APA
Vassal, G., Houghton, P. J., Pfister, S. M., Smith, M. A., Caron, H. N., Li, X., Shields, D. J., Witt, O., Molenaar, J. J., Colombetti, S., Schüler, J., & Stancato, L. F. (2021). International Consensus on Minimum Preclinical Testing Requirements for the Development of Innovative Therapies For Children and Adolescents with Cancer. Molecular Cancer Therapeutics. https://doi.org/10.1158/1535-7163.mct-20-0394
Source records
- crossref · retrieved 2026-09-27T14:05:57.264Z